Maumee, OH – CriticalPoint is pleased to announce that Dentsply Sirona Inc. (NASDAQ: XRAY) (“Dentsply Sirona”) has sold substantially all the assets of Ransom & Randolph Company (the “Company” or “R&R”) to PMC Capital Partners, LLC (“PMC”). Terms of the transaction were not disclosed.
Founded in 1872 and acquired by Dentsply Sirona in 1964, R&R is a leading manufacturer and distributor of specialty consumables to the global investment casting industry. The Company serves a broad range of markets including aerospace, defense, industrial gas turbine, automotive, commercial, jewelry, dental and art casting. R&R serves customers worldwide directly from its manufacturing facility in Maumee, Ohio as well as from various distribution centers. To learn more about R&R please visit: www.ransom-randolph.com.
Matt Coggin, Senior Vice President and Chief Strategy and Business Development Officer for Dentsply Sirona stated, “CriticalPoint Partners successfully ran a thorough M&A process to find a good home for R&R. PMC is sure to be a great steward for a business that has been around for nearly 150 years.”
CriticalPoint served as Dentsply Sirona’s exclusive financial advisor for the transaction.
About CriticalPoint
Headquartered in Los Angeles, CriticalPoint is a leading full-service financial M&A firm that uniquely combines the best of investment banking, private capital, and valuation service offerings. CriticalPoint executes, sources, and invests in deals across a wide variety of industries for the traditionally underserved middle market. Since our founding in 2012, our mission has been to serve the needs of owners, entrepreneurs, management teams, and stakeholders with our experience, knowledge, and expert judgment, to help them realize their companies’ greatest potential. From our deep-rooted foundation in private equity and investment banking, and our devotion to deal origination and business development, combined with being entrepreneurs at heart, we believe we are differentiated and well positioned to help companies wherever they are in their life cycle.
If you would like more information about CriticalPoint or have questions regarding this transaction, please contact:
Matt Young
Founder and CEO
Direct: (310) 321-4401
[email protected]
Christopher Ball
Managing Director
Direct: (310) 321-4403
[email protected]
Nicholas Cipiti
Director
Direct: (310) 321-4172
[email protected]
Messrs. Young, Ball, and Cipiti are Registered Representatives of and Securities Products are offered through CriticalPoint Partners, LLC Member FINRA, SIPC . Any testimonial or endorsement may not be representative of the experience of other customers and is no guarantee of future performance or success.
